Data Driven Discovery
Innovation drives antibody discovery. We deliver elusive antibodies in a short period of time, with high probability of succeeding to clinical trials.
Our multi-national team has the experience and expertise to accelerate your project.
Our subsidiary Talem Therapeutics has developed a rich and diverse discovery portfolio of SARS-CoV-2 candidate antibodies yielding epitope and functional diversity.